Tagged pages

CRIG seminar 'From Science to Startup: Disrupting 50 years of asparaginase treatment of acute lymphoblastic leukemia' by Prof. Arnon Lavie en Dr. Amanda M. Schalk
CRIG seminar 'Tackling ALK-positive neuroblastoma – lessons from ALK-driven model systems' by Prof. Ruth Palmer
CRIG seminar 'ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression' by prof. Bengt Hallberg
'Tumor metabolic acidosis: a key piece in the puzzle of colorectal cancer heterogeneity' - Lecture
PrIOMiC-OncoPoint symposium 2023
'High pressure nebulization of smart hydrogels: driving intraperitoneal drug delivery forward' - PhD defence
'A brighter future for medical imaging - Designing nanocrystals for in vivo applications' - PhD defence
'The impact of red meat metabolites on the metabolic flexibility of colon cancer cells' - PhD defence
4th CRIG industrial partnering event
'A study of dose, effects and (in)appropriate use of X-rays in medical imaging' - PhD defence
'Unlocking lncRNA functions through high-throughput CRISPR-interference screens in an in vitro airway inflammation model' - PhD defence
'Impact of epithelial-to-mesenchymal transition on regulated cell death and immune activation in colorectal carcinoma' - PhD defence
2nd GATE Academic - Industrial partnering event
CRIG's 2nd PhD welcome event!
2nd Building bridges in pediatric oncology symposium
‘Preclinical evaluation of target therapeutic strategies for high-risk neuroblastoma’ - PhD defence
'Novel glycoproteomics methodology for discovering tumor-specific, cell surface, glycopeptide epitopes' - PhD defence
'IRF2 and TXNIP: two regulators of human NK cell development and function' - PhD defence
'The synergy between biomechanics and medical research' - HSR Research Symposium
Oncolunch: 'Vloeibare biopten in de klinische oncologie: opportuniteiten en uitdagingen’
Subscribe to Past